<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/40701?offset=120</link>
	<atom:link href="https://bioinformaticsonline.com/related/40701?offset=120" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/44758/the-ifs-and-buts-of-ngs-quality-control-and-trimming</guid>
	<pubDate>Thu, 02 Jan 2025 20:11:07 -0600</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/44758/the-ifs-and-buts-of-ngs-quality-control-and-trimming</link>
	<title><![CDATA[The &quot;Ifs&quot; and &quot;Buts&quot; of NGS Quality Control and Trimming]]></title>
	<description><![CDATA[<p>Next-Generation Sequencing (NGS) has revolutionized biological research, providing vast amounts of data for a wide range of applications. However, the reliability of NGS analyses heavily depends on the quality of raw sequencing data. Quality control (QC) and trimming are critical preprocessing steps that can make or break your downstream analyses. In this blog, we explore the "ifs" (why you should perform QC and trimming) and the "buts" (challenges or considerations) of this vital step in NGS workflows.</p><h3><strong>The "Ifs" of NGS QC and Trimming</strong></h3><ol>
<li>
<p><strong>Ensures Data Integrity</strong><br />If you want to minimize errors in downstream analyses, QC and trimming remove low-quality reads and bases, ensuring high-confidence data. This step is essential for reliable variant calling, assembly, and other applications.</p>
</li>
<li>
<p><strong>Removes Contaminants</strong><br />If adapter sequences or contaminants are present in the raw reads, trimming can eliminate them. This prevents issues like misalignment or incorrect biological interpretations, ensuring cleaner data for analysis.</p>
</li>
<li>
<p><strong>Improves Mapping and Assembly</strong><br />If your goal is better alignment to a reference genome or improved de novo assembly, trimming low-quality bases and adapters is critical. High-quality reads map more efficiently and generate more accurate assemblies.</p>
</li>
<li>
<p><strong>Reduces Computational Load</strong><br />If you want to save computational resources, trimming reduces the dataset size, which speeds up processing and analysis. Clean datasets mean less computational time spent on processing low-quality data.</p>
</li>
<li>
<p><strong>Prepares for Standardized Analyses</strong><br />If your project involves multiple datasets, QC and trimming ensure uniformity across them. This standardization makes comparisons valid and reproducible, particularly in large collaborative studies.</p>
</li>
</ol><h3><strong>The "Buts" of NGS QC and Trimming</strong></h3><ol>
<li>
<p><strong>Risk of Over-Trimming</strong><br />But excessive trimming can lead to the loss of informative sequences, reducing read depth and potentially discarding biologically relevant data. This is especially critical in studies with limited sequencing depth.</p>
</li>
<li>
<p><strong>Bias Introduction</strong><br />But trimming algorithms might introduce biases, especially if they inadvertently remove sequences with specific biological patterns. This can skew results and compromise biological insights.</p>
</li>
<li>
<p><strong>Loss of Context in Paired-End Reads</strong><br />But trimming one read in a pair more than the other can lead to loss of pairing information. This complicates downstream analyses that rely on paired-end data, such as structural variant detection.</p>
</li>
<li>
<p><strong>Time and Resource Intensive</strong><br />But running QC and trimming for large datasets can be computationally expensive and time-consuming. As sequencing depth increases, preprocessing becomes a bottleneck in the analysis pipeline.</p>
</li>
<li>
<p><strong>Variable Standards</strong><br />But the criteria for trimming (e.g., quality threshold, minimum read length) can vary between tools and datasets. This variability may affect reproducibility and comparability of results across studies.</p>
</li>
</ol><h3><strong>Balancing the "Ifs" and "Buts"</strong></h3><p>To maximize the benefits of QC and trimming while mitigating the challenges, consider the following best practices:</p><ul>
<li>
<p><strong>Use QC Tools Wisely:</strong> Start with tools like <strong>FastQC</strong> to identify quality issues in your raw data. Visualizing quality metrics helps tailor your trimming parameters.</p>
</li>
<li>
<p><strong>Choose Reliable Trimming Tools:</strong> Tools like <strong>Trimmomatic</strong>, <strong>Cutadapt</strong>, and <strong>BBduk</strong> offer adaptive and customizable trimming options. Select one that aligns with your dataset and project goals.</p>
</li>
<li>
<p><strong>Set Reasonable Parameters:</strong> Avoid over-trimming by setting quality thresholds and minimum read lengths that balance data retention and quality improvement.</p>
</li>
<li>
<p><strong>Test Downstream Effects:</strong> Validate the impact of QC and trimming on downstream analyses, such as alignment efficiency, variant calling accuracy, or assembly quality.</p>
</li>
<li>
<p><strong>Document Your Workflow:</strong> Maintain detailed records of the parameters and tools used for QC and trimming. This ensures reproducibility and enables better troubleshooting.</p>
</li>
</ul><h3><strong>Conclusion</strong></h3><p>NGS quality control and trimming are essential steps to ensure reliable and accurate data for analysis. While the "ifs" highlight the clear benefits of these steps, the "buts" remind us of the potential pitfalls. By adopting best practices and carefully balancing these considerations, you can optimize your preprocessing workflow and unlock the full potential of your sequencing data.</p>]]></description>
	<dc:creator>BioStar</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/view/982</guid>
	<pubDate>Wed, 17 Jul 2013 15:25:09 -0500</pubDate>
	<link>https://bioinformaticsonline.com/view/982</link>
	<title><![CDATA[Is reference genome necessary for gene expression study in transcriptome sequencing or for variant discovery in genome sequencing?]]></title>
	<description><![CDATA[<p><span>Like in case of plant genomes where nature of genome is too complex and huge in size to accomplish complete<em> de novo</em> assembly by current sequencing technology. What would be alternate solution? Can we live in reference free world?</span></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/view/2044</guid>
	<pubDate>Mon, 12 Aug 2013 12:19:29 -0500</pubDate>
	<link>https://bioinformaticsonline.com/view/2044</link>
	<title><![CDATA[Does anyone have Nanopore latest updates?]]></title>
	<description><![CDATA[<p>There was a lot of buzz about&nbsp;<span>Oxford Nanopore Technologies&reg; is developing the GridION&trade; system and miniaturised MinION&trade; device. These are a new generation of electronic molecular analysis system for use in scientific research, personalised medicine, crop science, security/defence and more. The platform technology uses nanopores to analyse single molecules including DNA/RNA and proteins. With a broad patent portfolio, the Oxford Nanopore pipeline includes biological nanopores and solid-state nanopores.</span></p><p>Is this available, or still under trial mode?&nbsp;</p><p><a href="https://www.nanoporetech.com/">https://www.nanoporetech.com/</a></p><p><a href="https://www.nanoporetech.com/technology/the-minion-device-a-miniaturised-sensing-system/the-minion-device-a-miniaturised-sensing-system">https://www.nanoporetech.com/technology/the-minion-device-a-miniaturised-sensing-system/the-minion-device-a-miniaturised-sensing-system</a></p>]]></description>
	<dc:creator>Poonam Mahapatra</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/4183/320000-viruses-in-mammals-yet-to-sequenced-in-future</guid>
	<pubDate>Tue, 03 Sep 2013 08:35:30 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/4183/320000-viruses-in-mammals-yet-to-sequenced-in-future</link>
	<title><![CDATA[320000 viruses in mammals yet to sequenced in future!!!]]></title>
	<description><![CDATA[<p>With current biological technique improvements, finally it is now possible to look at millions of unknown viruses at genomic level and understand the mechanism. According to available data, close to 70 per cent of emerging viral diseases such as HIV/AIDS, West Nile, Ebola, SARS, and influenza, are zoonoses - infections of animals that cross into humans.</p><p>To address the challenges of describing and estimating virodiversity, a team of investigators from Center for Infection and Immunity (CII) and EcoHealth Alliance began in jungles of Bangladesh - home to the flying fox.</p><p>Reference:</p><p><a href="http://economictimes.indiatimes.com/news/news-by-industry/et-cetera/mammals-harbour-at-least-320000-new-viruses/articleshow/22253268.cms">http://economictimes.indiatimes.com/news/news-by-industry/et-cetera/mammals-harbour-at-least-320000-new-viruses/articleshow/22253268.cms</a></p><p><a href="http://www.bbc.co.uk/news/science-environment-23932400">http://www.bbc.co.uk/news/science-environment-23932400</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/6130/rna-bioinformatics-and-high-throughput-analysis-jena</guid>
  <pubDate>Sat, 09 Nov 2013 20:03:56 -0600</pubDate>
  <link></link>
  <title><![CDATA[RNA Bioinformatics and High Throughput Analysis Jena]]></title>
  <description><![CDATA[
<p>Research Topics:</p>

<p>High Throughput Sequencing Analysis<br />Comparative Genomics<br />Identification and Annotation of Non-coding RNAs<br />Bioinformatic Analysis and System Biology of Viruses<br />Coevolution of Proteins and RNAs<br />Algorithmic Bioinformatics<br />Phylogenetic Analysis</p>

<p>http://www.rna.uni-jena.de/index.php</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/10093/bio-rad-acquires-gnubio</guid>
	<pubDate>Sat, 19 Apr 2014 10:36:36 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/10093/bio-rad-acquires-gnubio</link>
	<title><![CDATA[Bio-Rad Acquires GnuBIO]]></title>
	<description><![CDATA[<p>http://www.businesswire.com/news/home/20140411005331/en/Bio-Rad-Acquires-GnuBIO-Developer-Droplet-Based-DNA-Sequencing#.U1KXnPm1b8o</p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/10246/deadly-human-pathogen-cryptococcus-sequenced</guid>
	<pubDate>Fri, 25 Apr 2014 11:02:21 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/10246/deadly-human-pathogen-cryptococcus-sequenced</link>
	<title><![CDATA[Deadly Human Pathogen Cryptococcus  Sequenced]]></title>
	<description><![CDATA[<p><span>"Now, researchers have sequenced the entire genome and all the RNA products of the most important pathogenic lineage of Cryptococcus neoformans, a strain called H99. The results, which appear in&nbsp;</span><em>PLOS Genetics</em><span>, also describe a number of genetic changes that can occur after laboratory handling of H99 that make it more susceptible to stress, hamper its ability to sexually reproduce and render it less virulent."</span></p><p><span><strong>Source</strong>:</span></p><p><span>http://www.biosciencetechnology.com/news/2014/04/deadly-human-pathogen-cryptococcus-fully-sequenced</span></p><p><span><strong>Paper</strong>:</span></p><p><span>http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1004292</span></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/11249/how-to-sequence-the-human-genome-mark-j-kiel</guid>
	<pubDate>Fri, 30 May 2014 13:24:11 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/11249/how-to-sequence-the-human-genome-mark-j-kiel</link>
	<title><![CDATA[How to sequence the human genome - Mark J. Kiel]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/MvuYATh7Y74" frameborder="0" allowfullscreen></iframe>View full lesson: http://ed.ted.com/lessons/how-to-sequence-the-human-genome-mark-j-kiel

Your genome, every human's genome, consists of a unique DNA sequence of A's, T's, C's and G's that tell your cells how to operate. Thanks to technological advances, scientists are now able to know the sequence of letters that makes up an individual genome relatively quickly and inexpensively. Mark J. Kiel takes an in-depth look at the science behind the sequence.

Lesson by Mark J. Kiel, animation by Marc Christoforidis.]]></description>
	
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/file/view/13415/genomics-and-sequencing-approach-for-identification-of-biomarkers-to-assess-the-efficacy-of-tgf-%CE%B2ri-inhibitors-of-liver-cancer-in-vivo</guid>
	<pubDate>Tue, 05 Aug 2014 13:55:32 -0500</pubDate>
	<link>https://bioinformaticsonline.com/file/view/13415/genomics-and-sequencing-approach-for-identification-of-biomarkers-to-assess-the-efficacy-of-tgf-%CE%B2ri-inhibitors-of-liver-cancer-in-vivo</link>
	<title><![CDATA[Genomics and sequencing approach for identification of biomarkers to assess the efficacy of TGF-βRI inhibitors (of liver cancer) in vivo]]></title>
	<description><![CDATA[<p>Liver cancer is third leading cause of deaths and fourth most frequent occuring cancer worldwide. There are multiple signaling pathways responsible for causing cancer amongst which TGFb is most important cytokine whose signaling pathway promote cancer. However, main problem is to cure this cancer at late stage where we still have no treatment strategy to tackle this deadly cancer. &nbsp;Hence we need to find out new therapeutic target. One way is to look the relationships between mRNA, methylation and miRNA data of patients with different pathological conditions (cancer vs control either with inhibitor/not). MiRNA is small RNA molecules known to inhibit mRNA expression of particular gene by binding improperly to 3'UTR region of a gene and hence block binding of TF /translation of gene. CpG regions is known to located at promoter region of gene (5' UTR) and usually hypomethylated which allow to gene to transcribe and translate however sometime this region become hyper-methylated thats prevent expression of host gene. Thus , integration of these three data reveal new targets and pathways important for causing or preventing cancer and also reveal biomarker thats check the effects of inhibitor on signaling pathway underlying liver cancer.</p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
	<enclosure url="https://bioinformaticsonline.com/file/download/13415" length="26423" type="image/jpeg" />
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/23174/scaffolding-of-a-bacterial-genome-using-minion-nanopore-sequencing</guid>
	<pubDate>Tue, 07 Jul 2015 16:59:25 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/23174/scaffolding-of-a-bacterial-genome-using-minion-nanopore-sequencing</link>
	<title><![CDATA[Scaffolding of a bacterial genome using MinION nanopore sequencing]]></title>
	<description><![CDATA[<p><span>Second generation sequencing has revolutionized genomic studies. However, most genomes contain repeated DNA elements that are longer than the read lengths achievable with typical sequencers, so the genomic order of several generated contigs cannot be easily resolved. A new generation of sequencers offering substantially longer reads is emerging, notably the Pacific Biosciences (PacBio) RS II system and the MinION system, released in early 2014 by Oxford Nanopore Technologies through an early access program.</span></p><p>Address of the bookmark: <a href="http://www.nature.com/srep/2015/150707/srep11996/full/srep11996.html" rel="nofollow">http://www.nature.com/srep/2015/150707/srep11996/full/srep11996.html</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

</channel>
</rss>